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Abstract
Background The Norwood procedure consists of three
palliative operations, performed in neonates with hypoplastic
left heart syndrome. Especially the first stage (Norwood I) is
associated with the highest mortality rates in paediatric
cardiac surgery (up to 25%). During surgery, the aorta is
reconstructed and a systemic-to-pulmonary shunt is applied.
Originally the modified Blalock-Taussig shunt was used, but
recently the right-ventricle-to-pulmonary-artery shunt is in-
creasingly being employed. We reviewed the results of our
operative strategy, where an individualised choice of shunt is
made. Furthermore, attempts to reduce interstage mortality
(between Norwood I and II) were assessed.
Methods All neonates who underwent Norwood stage I
palliation from August 2004 until November 2010 were
included in this retrospective analysis. Mortality rates and
management strategies were compared.
Results Thirty-six patients were available for analysis.
Overall 30-day mortality was 5.6% (2 patients) and
interstage mortality after discharge was 14% (5 patients).
In 2006, a novel clinical protocol was introduced, aimed at
reduction of mortality during the interstage period. This
resulted in reduction of interstage mortality from 23% to
9% (3 of 13 infants, versus 2 of 23), with a cumulative
survival of 82% (maximum follow-up 4 years).
Conclusion Early surgical results following the Norwood
procedure using an individualised shunt choice are favourable.
Keywords Congenital heart disease.Hypoplastic left heart
syndrome.Survival.Mortality
Introduction
The Norwood procedure is the standard treatment for
hypoplastic left heart syndrome (HLHS). In this complex
congenital heart defect, occurring in 1 in 5000 live births, a
restricted foramen ovale during foetal life results in a
hypoplastic left ventricle, stenotic or atretic mitral and
aortic valves, and consequent hypoplasia of the ascending
aortic arch [1]. The diagnosis is usually made antenatally,
and treatment options include termination of the pregnancy,
compassionate care, or surgical palliation.
The Norwood trajectory is the most common surgical
procedure, and consists of three stages of repair, ultimately
resulting in a Fontan circulation. The first stage (Norwood
I) is performed at neonatal age and results in a univen-
tricular circulation. The stage II and III repairs are
performed at 4–6 months and 2 years, respectively, in
which first a partial, and later a total cavo-pulmonary
connection are constructed.
The first stage of the Norwood procedure is associated
with the highest mortality rates within the field of
congenital heart surgery, with reported early mortality rates
varying between 6 and 25% [2–6]. The procedure results in
the right ventricle providing systemic circulation through a
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warranted by the placement of a systemic-to-pulmonary
shunt. The original Norwood procedure includes the
modified Blalock-Taussig shunt (BT shunt): a tube graft
connecting the brachiocephalic artery to the right pulmo-
nary artery (Fig. 1). Perfusion through the shunt mainly
takes place during diastole, which entails the risk of a lower
perfusion pressure of the coronary arteries [7]. Therefore,
recently the right-ventricle-to-pulmonary-artery (RV-PA or
Sano) shunt has gained popularity [2]. This shunt type,
however, may negatively impact cardiac function in the
long term, due to the development of fibrotic tissue of the
right ventricle [6, 8]. In our centre the modified BTshunt is
used preferentially. However, in selected infants with
specific characteristics (low weight, very small ascending
aorta or severe tricuspid insufficiency) the RV-PA shunt is
employed.
Beyond survival of the Norwood I, the period between
the first and second stages is associated with high risk for
mortality. To reduce this interstage mortality at our centre,
from 2006 onwards, a new clinical protocol was introduced.
This consisted of the prolonged admission of high-risk
infants between Norwood stages I and II, and electively
performing the stage II repair at a younger age.
In this study, we reviewed the early surgical results of the
Norwood procedure at our centre and the impact of the
altered strategy during the interstage period.
Methods
Retrospectively, all consecutive infants who underwent the
Norwood procedure from August 2004 until November
2010 were reviewed. Demographic data were recorded, and
outcome data included mortality and unplanned re-
interventions. The ethical committee of our hospital waived
the need for parental consent for this study.
All patients underwent the procedure by the same surgical
team.Standardcardiopulmonarybypasstechniqueswereused
in all patients, including cooling to deep hypothermia. A
modified BT shunt was placed routinely, except when the
following patient characteristics were present: an ascending
aorta of <2 mm diameter, weight <2.5 kg at surgery or severe
tricuspid insufficiency; the RV-P A shunt was employed in
these cases.
During postoperative management on the paediatric
intensive care, a multidisciplinary team of paediatric
cardiothoracic surgeons, paediatric cardiac anaesthesiolo-
gists, paediatric cardiologists and paediatric intensivists was
involved. Extracorporeal membrane oxygenation (ECMO)
apparatus was not available during the study period.
Before November 2006, stage II repair was electively
planned at an age of 6 months, and patients awaited the
procedure at home. After this date, clinical practice during
the interstage was altered. Selected infants that did not
prove to be completely haemodynamically stable (i.e.
recurrent dips in oxygen saturation or a mean oxygen
saturation of <70% without additional oxygen) remained
admitted in hospital during this interstage period. Further-
more, in all patients efforts were made to routinely perform
the stage II repair at a younger age (from 2 to 4 months
onwards).
Stage III repair was subsequently planned at approxi-
mately 2 years of age.
Fig. 1 The two variants of the Norwood I procedure; with modified
BT shunt (top) and RV-PA shunt (bottom). Re-used with permission
from Ohye et al. [8]
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Group characteristics are displayed as medians and (inter-
quartile) ranges as appropriate. Actuarial survival analysis
was performed using Kaplan-Meier estimates, and a log-
rank test was used to compare survival before and after
2006. Analyses were performed with SPSS V ersion 15.0
(SPSS Inc, Chicago, Ill, USA).
Results
A total of 36 infants underwent the Norwood procedure,
with a median age of 7 (range 4–55) days and median
weight of 3.5 kg (range 1.8–4.6) at surgery. Twenty-four
neonates were diagnosed with classical HLHS, and the
remaining 12 had HLHS-associated anomalies.
Using the above-described considerations for shunt
choice, the modified BT shunt was used in 29 cases
(81%), as opposed to the RV-PA shunt in 7 cases (19%).
The proportion of either shunt type did not change during
the study period.
Two patients died within 30 days after the Norwood I
procedure (5.6%), both due to low cardiac output syn-
drome. A modified BTshunt was used in one, RV-PA shunt
in the other. Unplanned re-interventions (surgical or by
interventional catheterisation) before stage II repair were
necessary in 6 infants (16.7%), of which half were due to
shunt obstructions.
For analysis of the effect of the altered management
protocol in the interstage period, neonates undergoing
surgery before and after 2006 were compared, resulting
in 13 neonates in the early period versus 23 in the later
period. The change in protocol resulted in a younger age
at stage II repair (median 4.5 versus 6 months). Stage III
repair was performed at a median age of 2 years in both
groups.
In the early period, interstage mortality (occurring after
discharge following the Norwood procedure and before
stage II repair) occurred in 3 neonates (23%). In the later
period, 2 of 23 infants died (9%). Later mortality was
incidental, with one patient within 30 days after stage III
repair due to a failing Fontan circulation.
Figure 2 shows the survival of infants before and after
2006 (p=0.19 between the two periods). In the current era,
survival to date is currently 82%, with a maximal follow-up
of 4 years.
Discussion
In the current surgical era, the Norwood procedure still
carries among the highest mortality rates within paediatric
cardiac surgery. In this study, we reviewed the results of our
recent surgical and management protocols in this high-risk
group, and found a favourable early mortality of 5.6%.
Overall mortality is largely dependent on patients who died
while awaiting their stage II repair, but the current
management protocols seem to have improved the overall
results markedly.
In recent literature, mortality rates for the first stage of
the Norwood procedure vary between 6 and 25% [2–6].
Choice of shunt type (modified BT versus RV-PA shunt)
has received much attention with controversial results [2,
4, 5, 9]. A large recently completed randomised controlled
multicentre trial comparing the two shunt types showed
higher survival in infants who had received the RV-PA
shunt at 1 year of age [8]. However, the RV-PA shunt was
associated with more unexpected re-interventions, mainly
due to shunt obstructions. At our centre, the choice for a
modified BT or RV-PA shunt is based on specific patient
characteristics. As the RV-PA shunt has the important
disadvantage of an incision in the systemic ventricle,
which may negatively impact ventricular function or lead
to ventricular arrhythmias, there is a preference for the
modified BT shunt. At our centre the RV-PA shunt is
reserved for low birth weight infants, where the modified
BT shunt may cause pulmonary overperfusion, and for
patients with a very small ascending aorta, as a lower
coronary perfusion pressure, often associated with use of
the modified BTshunt, may lead to myocardial ischaemia
in these patients. Finally, if severe tricuspid insufficiency
is present, the RV-P A shunt is employed due to the theoretical
advantage of reducing volume load of the right ventricle. In
ouropinionthisindividualisedapproachisthemainreasonfor
the low early mortality seen in our cohort.
Following discharge after the Norwood hospitalisation,
the interstage period is known to be associated with a
continued risk for mortality. Shunts may become
obstructed, or changes in systemic or pulmonary vascular
resistance may induce alterations in the ratio of systemic
and pulmonary perfusion. The prolonged admission of
selected neonates during this period, and the decision to
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Fig. 2 Kaplan-Meier survival curve
Neth Heart J (2011) 19:369–372 371routinely perform the stage II repair at a younger age in
all patients, resulted in a marked reduction of this
interstage mortality. This did not reach statistic signifi-
cance, presumably due to the relatively small sample
size. However, we cannot exclude that the reduced
mortality over the years also reflects improvements in
other (perioperative) management strategies that we are
not aware of at this time.
The cumulative effects of all these efforts have
resulted in the survival of 82%, with a maximal
follow-up of 4 years. Recently published survival rates
for 1 or 2 years of age vary between 64 and 81%, with
most mortality taking place shortly after the Norwood
procedure or during the interstage period [2, 4, 5, 8].
Over the years, survival after the Norwood procedure has
improved drastically since it was first performed in the 1980s
[10]. However, unfortunate side effects of these complex
cardiac procedures are becoming increasingly apparent.
Although the severity varies widely, up to 60% of children
surviving the entire trajectory suffer from a wide range of
neurocognitive deficits [2, 11]. The challenge is now to
unravel the mechanisms leading to cerebral injury.
In conclusion, when reviewing the recent results of the
Norwood procedure at our centre, a favourable surgical
outcome is observed. The individualised choice for shunt
type is regarded as an important factor. Beyond the first
stage, prolonged admittance of high-risk patients and early
timing of the stage II repair have likely contributed to
improved survival in this group.
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